These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14661170)

  • 1. Prognostic value of heart rate variability in patients with hypertrophic cardiomyopathy.
    Kawasaki T; Azuma A; Sakatani T; Hadase M; Kamitani T; Kawasaki S; Kuribayashi T; Sugihara H
    J Electrocardiol; 2003 Oct; 36(4):333-8. PubMed ID: 14661170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features.
    Counihan PJ; Fei L; Bashir Y; Farrell TG; Haywood GA; McKenna WJ
    Circulation; 1993 Oct; 88(4 Pt 1):1682-90. PubMed ID: 8403313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F; Olivotto I; Montereggi A; Squillatini G; Dolara A; Maron BJ
    Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.
    Magri D; Agostoni P; Sinagra G; Re F; Correale M; Limongelli G; Zachara E; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Morosin M; Musumeci B; Pagannone E; Maruotti A; Uguccioni M; Volpe M; Autore C
    Int J Cardiol; 2018 Nov; 271():125-131. PubMed ID: 30087038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate variability analysis based on time-frequency representation and entropies in hypertrophic cardiomyopathy patients.
    Clariá F; Vallverdú M; Baranowski R; Chojnowska L; Caminal P
    Physiol Meas; 2008 Mar; 29(3):401-16. PubMed ID: 18367814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.
    Fananapazir L; Chang AC; Epstein SE; McAreavey D
    Circulation; 1992 Sep; 86(3):730-40. PubMed ID: 1516184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes.
    D'Andrea A; Caso P; Cuomo S; Salerno G; Scarafile R; Mita C; De Corato G; Sarubbi B; Scherillo M; Calabrò R
    Br J Sports Med; 2006 Mar; 40(3):244-50; discussion 244-50. PubMed ID: 16505082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy?
    Fei L; Slade AK; Prasad K; Malik M; McKenna WJ; Camm AJ
    J Am Coll Cardiol; 1995 Aug; 26(2):472-80. PubMed ID: 7608453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.
    Monserrat L; Elliott PM; Gimeno JR; Sharma S; Penas-Lado M; McKenna WJ
    J Am Coll Cardiol; 2003 Sep; 42(5):873-9. PubMed ID: 12957435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the relationship between the ambulatory electrocardiography-based micro T-wave alternans and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
    Özyılmaz S; Püşüroğlu H
    Anatol J Cardiol; 2018 Sep; 20(3):165-173. PubMed ID: 30152798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
    J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of time and frequency domain, and spectral temporal mapping analysis of the signal-averaged electrocardiogram in identification of patients with hypertrophic cardiomyopathy at increased risk of sudden death.
    Kulakowski P; Counihan PJ; Camm AJ; McKenna WJ
    Eur Heart J; 1993 Jul; 14(7):941-50. PubMed ID: 8375420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate turbulence and clinical prognosis in hypertrophic cardiomyopathy and myocardial infarction.
    Kawasaki T; Azuma A; Asada S; Hadase M; Kamitani T; Kawasaki S; Kuribayashi T; Sugihara H
    Circ J; 2003 Jul; 67(7):601-4. PubMed ID: 12845183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Holter monitoring and long-term prognosis in hypertrophic cardiomyopathy.
    Kawasaki T; Sakai C; Harimoto K; Yamano M; Miki S; Kamitani T; Sugihara H
    Cardiology; 2012; 122(1):44-54. PubMed ID: 22722267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.
    Dinshaw L; Münch J; Dickow J; Lezius S; Willems S; Hoffmann BA; Patten M
    Clin Res Cardiol; 2018 Feb; 107(2):130-137. PubMed ID: 28965260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of clinical presentation in symptomatic patients with hypertrophic cardiomyopathy.
    Finocchiaro G; Pinamonti B; Merlo M; Brun F; Barbati G; Sinagra G
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):810-8. PubMed ID: 22885530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
    Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of syncope in patients with hypertrophic cardiomyopathy.
    Haghjoo M; Faghfurian B; Taherpour M; Fazelifar AF; Mohammadzadeh S; Alizadeh A; Sadr-Ameli MA
    Pacing Clin Electrophysiol; 2009 May; 32(5):642-7. PubMed ID: 19422586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.